UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (Right to Buy) (2) | Â (3) | 01/09/2016 | Common Stock | 50,000 | $ 7.5 | D | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Buchbinder Aby C/O ENZON PHARMACEUTICALS, INC. 20 KINGSBRIDGE ROAD PISCATAWAY, NJ 08854 |
 |  |  VP, Clinical Development |  |
/s/ Andrew Rackear, Attorney-In-Fact | 08/01/2011 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Includes 10,000 Restricted Stock Units granted by the Issuer pursuant to its 2011 Stock Option and Incentive Plan, qualified under Rule 16b-3(d), and vesting in full on May 11, 2014, if the Reporting Person remains employed by the Issuer on such date; and 41,667 Restricted Stock Units granted by the Issuer pursuant to its 2001 Incentive Stock Plan, qualified under Rule 16b-3(d), and vesting in full on September 22, 2013, if the Reporting Person remains employed by the Issuer on such date. The Restricted Stock Units do not have an expiration date, and each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock. |
(2) | Option granted pursuant to Issuer's 2001 Incentive Stock Plan and qualified under Rule 16b-3(d). |
(3) | Options are fully-vested and exercisable. |
 Remarks: Exhibit List Exhibit 24.1 -  Power of Attorney |